Paul Alan Sobotka
About Paul Alan Sobotka
Paul Sobotka's Title and Role
Paul Sobotka serves as the Vice President of Clinical Research. He leverages his extensive background in transplant and heart failure to lead scientific inquiries and clinical studies aimed at advancing medical knowledge and patient care. His position involves coordinating with medical professionals and researchers to bring innovative healthcare solutions to market.
Paul Sobotka's Clinical and Scientific Expertise
Paul Sobotka has clinical and scientific expertise in the fields of transplant and heart failure. He has contributed significantly to medical literature, with over 200 peer-reviewed scientific articles published. His deep understanding of these areas makes him a thought leader and a key figure in research and clinical applications related to heart conditions.
Paul Sobotka's Entrepreneurial Ventures
Paul Sobotka has been a serial entrepreneur, founding several medical device start-up companies. His roles have included Chief Medical Officer at Ardian, CHF Solutions, ARTritech Med, ROX Med, and Advanced Heuristics. His entrepreneurial activities focus on developing innovative medical technologies aimed at improving patient outcomes.
Paul Sobotka's Advisory Roles
Paul Sobotka has served as a Medical Advisor to major companies like Medtronic and Merck Pharmaceutical. He provides expert guidance on medical research and clinical trial designs, helping these organizations develop and market effective medical devices and pharmaceuticals.
Paul Sobotka's Academic Contributions
Paul Sobotka has held prominent academic positions, including Professor of Medicine and Physiology at The Ohio State University and Loyola. He also served as Vice Chair of Medicine at Wayne State University. His academic work has focused on educating future medical professionals and advancing research in medicine and physiology.
Paul Sobotka's Role at the FDA
Paul Sobotka was an Entrepreneur-in-Residence at the White House, with a specific assignment to the FDA. In this role, he contributed his entrepreneurial insights and medical expertise to regulatory processes, aiming to enhance the efficiency and effectiveness of the FDA's operations.